Human Longevity’s valuation reportedly plummets

Human Longevity, a La Jolla developer of health and disease-prevention technologies, appears to be in a cash crunch, according to a Friday article in the Wall Street Journal.

The company, co-founded by genomics pioneer J. Craig Venter, is raising up to $25 million in a financing round that values…